SC 13G/A: Mineralys Therapeutics, Inc.

AI Summary

SC 13G/A filing by Mineralys Therapeutics, Inc..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.0001 — f Securities: Common Stock, par value $0.0001 per share (Common Stock). (e) CUSIP

Filing Documents

• d847797dsc13ga.htm (SC 13G/A) — 89KB
• 0001193125-24-257204.txt ( ) — 91KB

From the Filing

SC 13G/A 1 d847797dsc13ga.htm SC 13G/A SC 13G/A Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Mineralys Therapeutics, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 603170101 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 603170101 Schedule 13G Page 1 of 9 1 Names of Reporting Persons Catalys Pacific Fund, LP 2 Check the Appropriate Box if a Member of a Group (a)(b) 3 SEC Use Only 4 Citizenship or Place of Organization Cayman Islands Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power 0 6 Shared Voting Power 8,681,245 7 Sole Dispositive Power 0 8 Shared Dispositive Power 8,681,245 9 Aggregate Amount Beneficially Owned by Each Reporting Person 8,681,245 10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares Not Applicable 11 Percent of Class Represented by Amount in Row 9 17.4% 12 Type of Reporting Person PN CUSIP No. 603170101 Schedule 13G Page 2 of 9 1 Names of Reporting Persons Catalys Pacific Fund GP, LP 2 Check the Appropriate Box if a Member of a Group (a)(b) 3 SEC Use Only 4 Citizenship or Place of Organization Cayman Islands Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power 0 6 Shared Voting Power 8,681,245 7 Sole Dispositive Power 0 8 Shared Dispositive Power 8,681,245 9 Aggregate Amount Beneficially Owned by Each Reporting Person 8,681,245 10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares Not Applicable 11 Percent of Class Represented by Amount in Row 9 17.4% 12 Type of Reporting Person PN CUSIP No. 603170101 Schedule 13G Page 3 of 9 1 Names of Reporting Persons Catalys Pacific, LLC 2 Check the Appropriate Box if a Member of a Group (a)(b) 3 SEC Use Only 4 Citizenship or Place of Organization Cayman Islands Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power 0 6 Shared Voting Power 8,681,245 7 Sole Dispositive Power 0 8 Shared Dispositive Power 8,681,245 9 Aggregate Amount Beneficially Owned by Each Reporting Person 8,681,245 10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares Not Applicable 11 Percent of Class Represented by Amount in Row 9 17.4% 12 Type of Reporting Person OO CUSIP No. 603170101 Schedule 13G Page 4 of 9 1 Names of Reporting Persons Brian Taylor Slingsby 2 Check the Appropriate Box if a Member of a Group (a)(b) 3 SEC Use Only 4 Citizenship or Place of Organization United States of America Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power 0 6 Shared Voting Power 8,681,245 7 Sole Dispositive Power 0 8 Shared Dispositive Power 8,681,245 9 Aggregate Amount Beneficially Owned by Each Reporting Person 8,681,245 10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares Not Applicable 11 Percent of Class Represented by Amount in Row 9 17.4% 12 Type of Reporting Person IN CUSIP No. 603170101 Schedule 13G Page 5 of 9 ITEM1. (a) Name of Issuer: Mineralys Therapeutics, Inc. (the Issuer). (b) Address of Issuers Principal Executive Offices: 150 N. Radnor Chester Rd, Suite F200, Radnor, PA 19087 ITEM2. (a) Name of Person Filing: Each of the following is hereinafter individually referred to as a Reporting Person and collectively as the Reporting Persons. This statement is filed on behalf of: Catalys Pacific Fund, LP Catalys Pacific Fund GP, LP Catalys Pacific, LLC Brian Taylor Slingsby (b) Address or Principal Business Office: The principal business address for Catalys Pacific Fund, LP, Catalys Pacific Fund GP, LP and Catalys Pacific, LLC is PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands. The principal business address for Brian Taylor Slingsby is 1516 Bi

View Full Filing

View this SC 13G/A filing on SEC EDGAR